'%2F%3E%3Cpath%20d%3D'M11%205H21M13.5%205V11.6A8.5%208.5%200%201%200%2018.5%2011.6V5'%20fill%3D'none'%20stroke%3D'%23fff'%20stroke-width%3D'3.4'%20stroke-linecap%3D'round'%20stroke-linejoin%3D'round'%2F%3E%3Cpath%20d%3D'M10.6%2019.6L13.9%2021.8L17.6%2018.4L21.4%2020.4'%20fill%3D'none'%20stroke%3D'%23fff'%20stroke-width%3D'2.6'%20stroke-linecap%3D'round'%20stroke-linejoin%3D'round'%2F%3E%3Ccircle%20cx%3D'17.6'%20cy%3D'18.4'%20r%3D'2.6'%20fill%3D'%23fff'%2F%3E%3C%2Fsvg%3E){kind=small}
Anlon Healthcare Limited
AHCL (NSE) · AHCL (BSE 544497) · ISIN INE0Y8W01025 · Pharmaceuticals · Est. 2013 · listed 2025 · website
ASM Long term Stage 1 · BSE ASM Long term Stage 1 · NSE
In Q1 FY27 (quarter to 30 June 2026, standalone), revenue was ₹30.98 cr and profit after tax ₹4.8 cr. Revenue was 7% lower than in Q1 FY26.
Open the full company file Every section, filings and your notes, in the app.
Quarterly results
| Quarter | Revenue | Profit after tax | EPS (₹) | Filed |
|---|---|---|---|---|
| Q1 FY27 standalone | ₹30.98 cr | ₹4.8 cr | 0.09 | 30 Jul 2026 |
| Q4 FY26 standalone | ₹55.42 cr | ₹9.79 cr | 2.15 | 29 May 2026 |
| Q3 FY26 standalone | ₹35.58 cr | ₹5.15 cr | 1.13 | 1 May 2026 |
| Q2 FY26 standalone | ₹52.2 cr | ₹9.32 cr | 2.22 | 11 Nov 2025 |
| Q1 FY26 standalone | ₹33.3 cr | ₹3.55 cr | 4.44 | 13 Apr 2026 |
Balance sheet
| As of | Total equity | Borrowings | Total assets |
|---|---|---|---|
| 31 Mar 2026 standalone | ₹209.77 cr | ₹45.6 cr | ₹317.2 cr |
| 30 Sep 2025 standalone | ₹214.32 cr | ₹57.83 cr | ₹309.48 cr |
Shareholding
| Promoter | FII | DII | Public |
|---|---|---|---|
| 52.68% | 1.67% | 1.22% | 47.32% |
Latest filings
- SDD Compliance Certificate as per Regulation 3(5) and 3(6) of Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 19 October 2026 · NSE
- Anlon Healthcare Limited has informed the Exchange regarding Outcome of Board Meeting held on October 13, 2026. 13 October 2026 · NSE
- Annual Report FY2025-26 (New) 14 August 2026 · NSE
- Anlon Healthcare Limited has informed the Exchange regarding Outcome of Board Meeting held on August 13, 2026. 13 August 2026 · NSE
- Anlon Healthcare Limited has informed the Exchange about Transcript 12 August 2026 · NSE
Other companies in Pharmaceuticals
- Lupin Limited
- Sun Pharmaceutical Industries Limited
- Torrent Pharmaceuticals Limited
- Zydus Lifesciences Limited
- Ajanta Pharma Limited
- Alivus Life Sciences Limited
- Wockhardt Limited
- Morepen Laboratories Limited
Figures as filed by the company with NSE and BSE; surveillance status from the exchanges' lists. Updated 19 October 2026.
Information and calculation tools by Rachid Asen. Not investment advice or research. Facts from company filings and the exchanges' lists, for information only; not a recommendation to buy, sell or hold. Verify with the exchange.